Skip to main content
April 19, 2021
Andrew Penn, RN, MS, NP, CNS, APRN-BC, founding member of the Organization of Psychedelic and Entheogenic Nurses (OPENurses) and a Sana Symposium steering committee member, discusses psychedelics that mental health professionals should be familiar with, including ketamine, MDMA and psilocybin-…
April 05, 2021
Psychedelic Medicine Association president Lynn Marie Morski, MD, Esq., a Sana Symposium steering committee member, discusses the mission of the Psychedelic Medicine Association, bringing psychedelics education to front-line providers who are receiving inquiries from curious patients, and what PMA…
March 22, 2021
Sana Symposium steering committee member Rakesh Jain, MD, MPH, clinical professor in the Department of Psychiatry at the Texas Tech University Health Sciences Center School of Medicine and co-investigator for Psychedelics and Wellness Studies, discusses key research findings around psychedelic…
March 11, 2021
Psych Congress co-chair and researcher Charles Raison, MD, recently spoke with David Van Nuys, PhD, on the Shrink Rap Radio podcast about depression, traditional antidepressants, and psychedelic-assisted psychotherapy.
February 19, 2021
With the approval of psychedelic medicines imminent, the Psychiatry & Behavioral Health Learning Network (PBHLN) has announced that its inaugural Sana Symposium will take place Sept. 17-19, 2021.
February 07, 2019
Psychedelics researcher Robin Carhart-Harris, PhD, who delivered the opening session at Psych Congress 2018, spoke about the compounds at the World Economic Forum Annual Meeting in Davos, Switzerland.
October 24, 2016
Psych Congress Steering Committee members Andrew Penn, RN, MS, NP, CNS, APRN-BC, and Saundra Jain, MA, PsyD, LPC, discuss the latest research on the use of psychedelics with psychotherapy.
Back to Top